EFFECTS OF THE SYNTHETIC ANTIOXIDANT, PROBUCOL, ON THE U937 MONOBLASTOID CELL-LINE

被引:5
作者
FAULKNER, L
ARUOMA, OI
BRICKELL, PM
DAVIES, MJ
HALLIWELL, B
WOOLF, N
KATZ, DR
机构
[1] UNIV COLL & MIDDLESEX SCH MED LONDON, DEPT BIOCHEM & MOLEC BIOL, MED MOLEC BIOL UNIT, LONDON W1P 6BD, ENGLAND
[2] UNIV LONDON KINGS COLL, PHARMACOL GRP, LONDON SW3 6LX, ENGLAND
[3] ST GEORGE HOSP, BLAND SUTTON INST, LONDON, ENGLAND
关键词
PROBUCOL; U937; CELLS; CD16; MONOCYTE DIFFERENTIATION; ANTIOXIDANT;
D O I
10.1016/0021-9150(93)90045-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Probucol is a clinically important drug that decreases plasma cholesterol in humans and has a marked anti-atherogenic effect in hyperlipidaemic Watanabe rabbits. The action of probucol in this animal model has been partly attributed to its anti-oxidant abilities. Probucol can decrease the oxidative modification of low-density lipoprotein and hence diminish its uptake by macrophages. In this paper, we have examined the effect of probucol on the monoblastic cell line U937 and on U937 cells induced to differentiate towards a macrophage phenotype by 1,25-dihydroxycholecalciferol (DHCC), tumour necrosis factor-alpha (TNF-alpha) or phorbol myristate acetate (PMA). We found that probucol enhanced the proliferation of undifferentiated U937 cells. Probucol also enhanced proliferation in cultures that had been pre-treated with DHCC or TNF-alpha, but had no effect on cultures that had been pre-treated with PMA. In contrast, when U937 cells were treated simultaneously with probucol and DHCC or TNF-alpha, there was a more marked decrease in proliferation than was induced by these agents in the absence of probucol. Probucol had little effect on the phenotype of resultant cells. The surface expression of CD13 (aminopeptidase N), CD4, CD35 (C3b receptor), CD64 (FcyRI), CD71 (transferrin receptor) and HLA Class II was not affected by probucol. Probucol treatment led to a small increase in the surface expression of CD16 (FcgammaRIII) in TNF-alpha treated cells and to a small decrease in the expression of CD14 (a monocyte marker) in PMA-treated cells. The induction of c-fgr mRNA and TNF-alpha mRNA by DHCC or PMA or TNF-alpha was not significantly altered in the presence of probucol. The affect of probucol on U937 cells does not appear to be due to its anti-oxidant abilities because butylated hydroxytoluene (BHT), an equally powerful anti-oxidant, did not have the same effect on the cell proliferation as probucol and because no changes were detected in the levels of lipid peroxidation in U937 cell culture, supernatants.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 54 条
[1]   INCREASED LEVELS OF MESSENGER RIBONUCLEIC-ACID FOR APOLIPOPROTEIN-E IN THE SPLEEN OF PROBUCOL-TREATED RABBITS [J].
ABURATANI, H ;
MATSUMOTO, A ;
KODAMA, T ;
TAKAKU, F ;
FUKAZAWA, C ;
ITAKURA, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (03) :B60-B65
[2]  
ALSONSO S, 1986, J MOL EVOL, V23, P11
[3]   THE MECHANISM OF INITIATION OF LIPID-PEROXIDATION - EVIDENCE AGAINST A REQUIREMENT FOR AN IRON(II) IRON(III) COMPLEX [J].
ARUOMA, OI ;
HALLIWELL, B ;
LAUGHTON, MJ ;
QUINLAN, GJ ;
GUTTERIDGE, JMC .
BIOCHEMICAL JOURNAL, 1989, 258 (02) :617-620
[4]  
BARNHART RL, 1989, J LIPID RES, V30, P1703
[5]  
BHALLA AK, 1991, IMMUNOLOGY, V72, P61
[6]   ALPHA-TOCOPHEROL (VITAMIN-E) REGULATES VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND PROTEIN-KINASE-C ACTIVITY [J].
BOSCOBOINIK, D ;
SZEWCZYK, A ;
AZZI, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 286 (01) :264-269
[7]   STRUCTURE AND EXPRESSION OF C-FGR PROTOONCOGENE MESSENGER-RNA IN EPSTEIN-BARR VIRUS CONVERTED CELL-LINES [J].
BRICKELL, PM ;
PATEL, M .
BRITISH JOURNAL OF CANCER, 1988, 58 (06) :704-709
[8]  
Buege J A, 1978, Methods Enzymol, V52, P302
[9]   HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR INDUCES EXPRESSION OF THE TUMOR-NECROSIS-FACTOR GENE BY THE U937 CELL-LINE AND BY NORMAL HUMAN-MONOCYTES [J].
CANNISTRA, SA ;
RAMBALDI, A ;
SPRIGGS, DR ;
HERRMANN, F ;
KUFE, D ;
GRIFFIN, JD .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (06) :1720-1728